Kuwait | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2011 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Kuwait totalled $ 43 million in 2023. Sales of commodity group 30 from Kuwait went up by 628% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 37 million (cumulative exports of commodity group 30 from Kuwait amounted $5.96 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.051% of total exports from Kuwait (cumulative merchandise exports from Kuwait totalled $ 83 billion in 2023). The share of commodity group 30 in total exports from Kuwait increased by 0.032 p.p. compared to 2022 (it was 0.019% in 2022 and cumulative exports from Kuwait were equal to $ 30 billion).
Where does Kuwait export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Kuwait in 2023:
- Saudi Arabia with a share of 44% (19.4 million US$)
- United Arab Emirates with a share of 35% (15.4 million US$)
- Qatar with a share of 8.38% (3.64 million US$)
- Bahrain with a share of 5.3% (2.3 million US$)
- Oman with a share of 4.17% (1.81 million US$)
- Jordan - 151 thousand US$
- Yemen - 148 thousand US$
- Turkey - 146 thousand US$
- Denmark - 113 thousand US$
- Iraq - 110 thousand US$
Exports structure of 30 - Pharmaceutical products - from Kuwait in 2023 represented by the following main commodity groups:
- 97% (42 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.18% (516 thousand US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 0.81% (352 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.232% (101 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
The value of imports of commodity group 30 "Pharmaceutical products" to Kuwait totalled $ 1.88 billion in 2023. Sales of commodity group 30 to Kuwait went up by 286% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 1.39 billion (the value of imports of commodity group 30 to Kuwait was equal to $487 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 5.01% of total import flow to Kuwait (in 2023, total imports to Kuwait amounted to $ 37 billion). The share of commodity group 30 in total imports to Kuwait increased by 0.591 p.p. compared to 2022 (it was 4.42% in 2022 and cumulative imports to Kuwait were equal to $ 11 billion).
Where does Kuwait import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Kuwait in 2023:
- Germany with a share of 18.4% (346 million US$)
- USA with a share of 16.5% (310 million US$)
- Switzerland with a share of 9.86% (185 million US$)
- France with a share of 9.49% (178 million US$)
- Italy with a share of 6.12% (115 million US$)
- Ireland with a share of 5.16% (97 million US$)
- United Kingdom with a share of 4.17% (78 million US$)
- Spain with a share of 3.7% (69 million US$)
- Denmark with a share of 3.54% (66 million US$)
- Belgium with a share of 2.82% (53 million US$)
Imports structure of 30 - Pharmaceutical products - to Kuwait in 2023 represented by the following main commodity groups:
- 72% (1.36 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 22% (421 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.95% (55 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.1% (20 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.73% (13.7 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.089% (1.69 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
